IPO Issue Details
Issue Price / Price Band₹142 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,000 Shares per Lot
Total Issue Size48,92,000 shares (aggregating up to ₹69.47 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenFri, 08 Aug 2025
Subscription CloseTue, 12 Aug 2025
Anchor AllotmentThu, 07 Aug 2025
Basis of AllotmentWed, 13 Aug 2025
Initiation of RefundsThu, 14 Aug 2025
Credit of Shares to DematThu, 14 Aug 2025
Listing DateMon, 18 Aug 2025
UPI Mandate Deadline2025-08-12
Application & Investment Details
Retail — Min (2 Lots)₹2,84,000 — 2000 shares
Retail — Max (13 Lots)₹1,846,000 (13 Lots)
HNI — Min (3 Lots)₹4,26,000 — 3000 shares
EPS (Pre-IPO)₹11.82
EPS (Post-IPO)₹9.16
P/E Ratio (Pre-IPO)12.01x
P/E Ratio (Post-IPO)15.5x
Net Offer to Public44,12,000 shares (aggregating up to ₹62.65 Cr)
Reserved for Market Maker4,80,000 shares (aggregating up to ₹6.82 Cr)
Pre-IPO Promoter Holding1,35,00,000 shares
Post-IPO Promoter Holding1,74,20,000 shares
Fresh Issue Shares34,40,000 shares (aggregating up to ₹48.85 Cr)
Offer for Sale Shares9,72,000 shares of ₹10 (aggregating up to ₹13.80 Cr)
About Star Imaging & Path Lab Ltd.
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.The company specializes in imaging services such as X-rays, ultrasounds, CT scans, MRIs, and laboratory tests, including blood tests, urine tests, and other specialized diagnostics.With advanced technology and experienced medical professionals, the company aims to offer accurate and timely reports to patients, helping healthcare providers in effective diagnosis and treatment.The company has a strong presence in multiple regions, offering services to both individuals and healthcare institutions.Services:Radiology: Digital X-ray, Mammography, CT scans, 4D & 5D ultrasound services.Pathology: Haematology, Microbiology, PCR (polymerase chain reaction), HistopathologyDiagnotics: Routine Testing, Special TestingAs of September 30th 2024, the company has 209 full time employees including executive directors.Competitive Strengths:Accurate DiagnosisSpecialized ExpertiseProper Sample Collection and Processing Procedures
Objects of the Issue
Star Imaging & Path Lab Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 To Meet Working Capital Requirement
25.00
2
2 Repayment/prepayment of certain borrowings availed of by the Company
12.00
3
3 Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities
5.14
4
4 General corporate purposes
6.94
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,35,00,000 shares
Post-IPO Promoter Holding
1,74,20,000 shares